Description
This report provides the reader with a comprehensive analysis of the domestic and international markets involving pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatologic Drugs is the fourth time Kalorama Information has comprehensively studied the dermatology markets.
For this latest edition, Kalorama completely re-evaluated the market from the ground up, and in addition to the usual primary interviewing of industry participants, clinicians, and regulators, we also conducted scores of interviews with users of Kalorama’s 2000 and 2002 dermatological studies to ensure that the current report contains the best possible data and the most useful analysis. Some of the reader-inspired changes in the current edition include a greatly expanded exploration of some “hot” topics such as psoriasis and added information on pipeline products in all therapeutic areas.
Market information is available for the years 1998 to 2008, with the focus year 2003. Overview and product descriptions of general adjunctive therapy segments are covered, including prescription drugs to treat:
- Acne and Rosacea
- Antiaging and Photodamage
- Dermatitis and Seborrhea
- Fungal Infections
- Hair Loss and Hair Removal
- Hyperpigmentation/Melasma
- Psoriasis
- Skin Cancer , and
- Other Skin Disorders
Other data points include competitive market share, demographics, epidemiology, and geographic break down. The study covers issues and trends affecting the market, research and developments, and more. In particular, the study explores the current and potential effects of the aging baby boomers on the prescription dermatology market and the continued demand for lifestyle drugs. Profiles of major market participants are included.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Scope and Methodology
- Size and Growth of the Market
- Issues and Trends Affecting Market
- Competitor Analysis
CHAPTER TWO: INTRODUCTION
- Structure and Function of the Skin
- Epidermis
- Dermis
- Subcutaneous Tissue
- Epidermal Appendages
- Functions of the Skin
- Effects of Aging on the Skin
- Dermatological Conditions and Treatment
- Pharmacokinetics
- Drug Absorption
- Distribution
- Bioavailability
- Drug Delivery Methods
- Demographics of Skin Disorders, Incidence, and Prevalence
CHAPTER THREE: ISSUES AND TRENDS
- Cosmetic Dermatologists
- New Filler Options
- A Confusing Industry
- Genetic Link to Psoriasis
- Biologic Dermatology
- Rx-to-OTC Switches
- Cosmeceuticals
- Teledermatology
- Reimbursement Issues
- Laser Therapy
- Narrowband Ultraviolet B
- Photodynamic Therapy
- Importance of Drug Delivery
CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS
- Description of Disorders
- Description of Products
- Benzoyl Peroxide
- Retinoids
- Antibiotics
- Oral Contraceptives
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- The Future of the Market
- Competitive Analysis
CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS
- Overview
- Description of Products
- Keratolytics
- Moisturizers
- Retinoids
- Sunscreens
- Other Agents
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- The Future of the Market
- Competitive Analysis
CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS
- Overview
- Description of Products
- Topical Corticosteroids
- Systemic Corticosteroids
- Other Products
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- Future of the Market
- Competitive Analysis
CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS
- Overview
- Description of Products
- Systemic Formulations
- Topical Formulations
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- Future of the Market
- Competitive Analysis
CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS
- Overview
- Description of Products
- Antiandrogens
- Androgen Inhibitors
- Oral Contraceptives
- Other Treatments
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- Future of the Market
- Competitive Analysis
CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION/ MELASMA DRUGS
- Overview
- Description of Products
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- The Future of the Market
- Competitive Analysis
CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS
- Overview
- Description of Products
- Topical Psoriasis Products
- Systemic Psoriasis Preparations
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- Future of the Market
- Competitive Analysis
CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS
- Overview
- Nonmelanoma Skin Cancers
- Malignant Melanoma
- Description of Products
- 5-Fluorouracil
- Mechlorethamine/Nitrogen Mustard
- Carmustine/BCNU (Topical)
- Vinblastine (Intralesional) and Others
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- The Future of the Market
- Competitive Analysis
CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS—ANTIVIRALS AND ANTIPARASITICS
- Overview
- Antivirals
- Antiparasitics
- Description of Products
- Topical Antivirals
- Antiparasitic Agents
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- The Future of the Market
- Competitive Analysis
CHAPTER THIRTEEN: WORLD MARKET SUMMARY
- Overview
- Total Market Size and Forecast
- Market and Competitive Analysis
CHAPTER FOURTEEN: CORPORATE PROFILES
- Bayer AG
- Bertek Pharmaceuticals, Inc.
- Bristol-Myers Squibb
- Galderma S.A.
- Genentech, Inc.
- GlaxoSmithKline Plc
- Inamed Corporation
- Johnson & Johnson, Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil
- Medicis Pharmaceutical Corporation
- Merck & Company, Inc.
- Novartis Pharmaceuticals Corporation
- Pfizer, Inc
- Q-Med AB
- Roche Group (F. Hoffmann-La Roche Ltd.)
- Schering-Plough Corporation
- Valeant Pharmaceuticals, Inc
APPENDIX: COMPANY DIRECTORY
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: The Global Market for Prescription Dermatological Drugs 1998, 2003, and 2008
- Figure 1-1: The Global Market for Prescription Dermatological Drugs 1998, 2003, and 2008
CHAPTER TWO: INTRODUCTION
- Table 2-1: Common Bases for Topical Dermatological Medications
- Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic Conditions
CHAPTER THREE: ISSUES AND TRENDS
- Table 3-1: Selected Dermatological Rx-to-OTC Switches
- Table 3-2: Selected Potential Prescription Dermatological Rx-to-OTC Switches
CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS
- Table 4-1: Common Benzoyl Peroxide Formulations
- Table 4-2: Common Retinoid Formulations
- Table 4-3: Common Antibiotic Formulations
- Table 4-4: Common Oral Contraceptive Formulations
- Table 4-5: Prescription Acne and Rosacea Formulations in Development
- Table 4-6: The Global Market for Prescription Acne and Rosacea Drugs by Type 1998-2008
- Figure 4-1: The Global Market for Prescription Acne and Rosacea Drugs Revenues by Type 1998-2008
- Table 4-7: The Global for Prescription Acne and Rosacea Drugs, Market Share by Type 1998-2008
- Figure 4-2: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2003
- Figure 4-3: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2008
- Table 4-8: The Global Market for Prescription Antiacne and Rosacea Drugs by Geographical Region 1998-2008
- Figure 4-4: The Global Market for Prescription Antiacne and Rosacea Drugs Revenues by Geographical Region 1998-2008
- Table 4-9: The Global for Prescription Antiacne and Rosacea Drugs Market Share by Geographical Region 1998-2008
- Figure 4-5: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2003
- Figure 4-6: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2008
- Table 4-10: The U.S. Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
- Figure 4-7: The U.S. Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
- Table 4-11: The European Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
- Figure 4-8: The European Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
- Table 4-12: The Japanese Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
- Figure 4-9: The Japanese Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
- Table 4-13: The Rest of World Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
- Figure 4-10: The Rest of World Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
- Table 4-14: Global Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier 2003
- Figure 4-11: Global Market for Acne and Rosacea Drugs Market Share by Leading Supplier 2003
CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS
- Table 5-1: Common Prescription Keratolytic Formulations
- Table 5-2: Occlusive Moisturizers—Categories of Ingredients
- Table 5-3: Common Prescription Moisturizers
- Table 5-4: Common Prescription Retinoids for Antiaging and Photodamage
- Table 5-5: Common Prescription Sunscreens
- Table 5-6: Prescription Other Antiaging and Photodamage Products
- Table 5-7: Prescription Antiaging and Photodamage Formulations in Development
- Table 5-8: The Global Market Antiaging and Photodamage Drugs by Type 1998-2008
- Figure 5-1: The Global Market for Antiaging and Photodamage Drugs Revenues by Type 1998-2008
- Table 5-9: The Global for Antiaging and Photodamage Drugs Market Share by Type 1998-2008
- Figure 5-2: The Global Market for Antiaging and Photodamage Drugs Share by Type 2003
- Figure 5-3: The Global Market for Antiaging and Photodamage Drugs Share by Type 2008
- Table 5-10: The Global Market for Prescription Antiaging and Photodamage Drugs by Geographical Region 1998-2008
- Figure 5-4: The Global Market for Prescription Antiaging and Photodamage Drugs Revenues by Geographical Region 1998-2008
- Table 5-11: The Global Market for Prescription Antiaging and Photodamage Drugs Market Share by Geographical Region 1998-2008
- Figure 5-5: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2003
- Figure 5-6: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2008
- Table 5-12: The U.S. Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
- Figure 5-7: The U.S. Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
- Table 5-13: The European Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
- Figure 5-8: The European Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
- Table 5-14: The Japanese Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
- Figure 5-9: The Japanese Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
- Table 5-15: The Rest of World Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
- Figure 5-10: The Rest of World Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
- Table 5-16: Global Market for Prescription Antiaging and Photodamage Drugs Revenues and Market Share by Supplier 2003
- Figure 5-11: Global Market for Prescription Antiaging and Photodamage Drugs Market Share by Leading Supplier 2003
CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS
- Table 6-1: Common Prescription Topical Corticosteroid Preparations
- Table 6-2: Common Prescription Systemic Corticosteroids
- Table 6-3: Prescription Dermatitis Formulations in Development
- Table 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Type 1998-2008
- Figure 6-1: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Type 1998-2008
- Table 6-5: The Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Type 1998-2008
- Figure 6-2: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2003
- Figure 6-3: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2008
- Table 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Geographical Region 1998-2008
- Figure 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Geographical Region 1998-2008 133
- Table 6-7: The Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Geographical Region 1998-2008
- Figure 6-5: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2003
- Figure 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2008
- Table 6-8: The U.S. Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
- Figure 6-7: The U.S. Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
- Table 6-9: The European Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
- Figure 6-8: The European Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
- Table 6-10: The Japanese Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
- Figure 6-9: The Japanese Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
- Table 6-11: The Rest of World Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
- Figure 6-10: The Rest of World Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
- Table 6-12: Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues and Market Share by Supplier 2003
- Figure 6-11: Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Leading Supplier 2003
CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS
- Table 7-1: Common Prescription Systemic Antifungal Dermatological Formulations
- Table 7-2: Common Prescription Topical Antifungal Dermatological Drugs
- Table 7-3: Prescription Antifungal Dermatological Drugs in Development
- Table 7-4: The Global Market for Prescription Antifungal Dermatological Drugs by Type 1998-2008
- Figure 7-1: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Type 1998-2008
- Table 7-5: The Global for Prescription Antifungal Dermatological Drugs Market Share by Type 1998-2008
- Figure 7-2: The Global Market for Prescription Antifungal Dermatological Drugs Share by Type 2003
- Figure 7-3: The Global Market for Prescription Antifungal Dermatological Drugs Share by Type 2008
- Table 7-6: The Global Market for Prescription Antifungal Dermatological Drugs by Geographical Region 1998-2008
- Figure 7-4: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Geographical Region 1998-2008
- Table 7-7: The Global Market for Prescription Antifungal Dermatological Drugs Market Share by Geographical Region 1998-2008
- Figure 7-5: The Global Market for Prescription Antifungal Dermatological Drugs Share by Geographical Region 2003
- Figure 7-6: The Global Market for Prescription Antifungal Dermatological Drugs Share by Geographical Region 2008
- Table 7-8: The U.S. Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
- Figure 7-7: The U.S. Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
- Table 7-9: The European Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
- Figure 7-8: The European Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
- Table 7-10: The Japanese Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
- Figure 7-9: The Japanese Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
- Table 7-11: The Rest of World Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
- Figure 7-10: The Rest of World Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
- Table 7-12: Global Market for Prescription Antifungal Dermatological Drugs Revenues and Market Share by Supplier 2003
- Figure 7-11: Global Market for Prescription Antifungal Dermatological Drugs Market Share by Leading Supplier 2003
CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS
- Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
- Table 8-2: Prescription Hair Loss or Hair Removal Formulations in Development
- Table 8-3: The Global Market for Prescription Hair Loss and Hair Removal Drugs by Type 1998-2008
- Figure 8-1: The Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues by Type 1998-2008
- Table 8-4: The Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Type 1998-2008
- Figure 8-2: The Global Market for Prescription Hair Loss and Hair Removal Drugs Share by Type 2003
- Figure 8-3: The Global Market for Prescription Hair Loss and Hair Removal Drugs Share by Type 2008
- Table 8-5: The Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues by Geographical Region 1998-2008
- Figure 8-4: The Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues by Geographical Region 1998-2008
- Table 8-6: The Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Geographical Region 1998-2008
- Figure 8-5: The Global Market for Prescription Hair Loss and Hair Removal Drugs Share by Geographical Region 2003
- Figure 8-6: The Global Market for Prescription Hair Loss and Hair Removal Drugs Share by Geographical Region 2008
- Table 8-7: The U.S. Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
- Figure 8-7: The U.S. Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
- Table 8-8: The European Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
- Figure 8-8: The European Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
- Table 8-9: The Japanese Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
- Figure 8-9: The Japanese Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
- Table 8-10: The Rest of World Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
- Figure 8-10: The Rest of World Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
- Table 8-11: Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues and Market Share by Supplier 2003
- Figure 8-11: Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Leading Supplier 2003
CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION/ MELASMA DRUGS
- Table 9-1: Common Prescription Hyperpigmentation/Melasma Formulations
- Table 9-2: Common Prescription Depigmenting Agents
- Table 9-3: The Global Market for Hyperpigmentation/Melasma Drugs by Type 1998-2008
- Figure 9-1: The Global Market for Hyperpigmentation/Melasma Drugs Revenues by Type 1998-2008
- Table 9-4: The Global for Prescription Hyperpigmentation/Melasma Drugs, Market Share by Type 1998-2008
- Figure 9-2: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Type 2003
- Figure 9-3: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Share by Type 2008
- Table 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs by Geographical Region 1998-2008
- Figure 9-4: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Revenues by Geographical Region 1998-2008
- Table 9-6: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Market Share by Geographical Region 1998-2008
- Figure 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Geographical Region 2003
- Figure 9-6: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Geographical Region 2008
- Table 9-7: The U.S. Market for Prescription Hyperpigmentation/ Melasma Drugs Manufacturer Revenues 1998-2008
- Figure 9-7: The U.S. Market for Prescription Hyperpigmentation/ Melasma Drugs Manufacturer Revenues 1998-2008
- Table 9-8: The European Market for Prescription Hyperpigmentation/ Melasma Drugs Manufacturer Revenues 1998-2008
- Figure 9-8: The European Market for Prescription Hyperpigmentation/ Melasma Drugs Manufacturer Revenues 1998-2008
- Table 9-10: The Japanese Market for Prescription Hyperpigmentation/ Melasma Drugs Manufacturer Revenues 1998-2008
- Figure 9-10: The Japan Market for Prescription Hyperpigmentation/ Melasma Drugs Manufacturer Revenues 1998-2008
- Table 9-11: The Rest of World Market for Prescription Hyperpigmentation/ Melasma Drugs Manufacturer Revenues 1998-2008
- Figure 9-11: The Rest of World Market for Prescription Hyperpigmentation/ Melasma Drugs Manufacturer Revenues 1998-2008
CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS
- Table 10-1: Common Prescription Psoriasis Preparations
- Table 10-2: Prescription Psoriasis Preparations in Development
- Table 10-3: The Global Market for Prescription Psoriasis Drugs by Type 1998-2008
- Figure 10-1: The Global Market for Prescription Psoriasis Drugs Revenues by Type 1998-2008
- Table 10-4: The Global Market for Prescription Psoriasis Drugs Market Share by Type 1998-2008
- Figure 10-2: The Global Market for Prescription Psoriasis Drugs Share by Type 2003
- Figure 10-3: The Global Market for Prescription Psoriasis Drugs Share by Type 2008
- Table 10-5: The Global Market for Prescription Psoriasis Drugs by Geographical Region 1998-2008
- Figure 10-4: The Global Market for Prescription Psoriasis Drugs Revenues by Geographical Region 1998-2008
- Table 10-6: The Global Market for Prescription Psoriasis Drugs Market Share by Geographical Region 1998-2008
- Figure 10-5: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2003
- Figure 10-6: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2008
- Table 10-7: The U.S. Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
- Figure 10-7: The U.S. Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
- Table 10-8: The European Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
- Figure 10-8: The European Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
- Table 10-9: The Japanese Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
- Figure 10-9: The Japanese Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
- Table 10-10: The Rest of World Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
- Figure 10-10: The Rest of World Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
- Table 10-11: Global Market for Prescription Psoriasis Drugs Revenues and Market Share by Supplier 2003
- Figure 10-11: Global Market for Prescription Psoriasis Drugs Market Share by Leading Supplier 2003
CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS
- Table 11-1: Malignant Conditions of the Skin
- Table 11-2: Common Prescription Topical and Intralesional Chemotherapeutic Agents
- Table 11-3: Prescription Skin Cancer Preparations in Development
- Table 11-4: The Global Market for Skin Cancer Drugs 1998-2008
- Figure 11-1: The Global Market for Skin Cancer Drugs 1998-2008
- Table 11-5: The Global Market for Prescription Skin Cancer Drugs by Geographical Region 1998-2008
- Figure 11-2: The Global Market for Prescription Skin Cancer Drugs Revenues by Geographical Region 1998-2008
- Table 11-6: The Global for Prescription Skin Cancer Drugs Market Share by Geographical Region 1998-2008
- Figure 11-3: The Global Market for Prescription Skin Cancer Drugs Share by Geographical Region 2003
- Figure 11-4: The Global Market for Prescription Skin Cancer Drugs Share by Geographical Region 2008
- Table 11-7: The U.S. Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
- Figure 11-5: The U.S. Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
- Table 11-8: The European Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
- Figure 11-6: The European Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
- Table 11-9: The Japanese Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
- Figure 11-7: The Japanese Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
- Table 11-10: The Rest of World Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
- Figure 11-8: The Rest of World Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
- Table 11-12: Global Market for Prescription Skin Cancer Drugs Revenues and Market Share by Supplier 2003
- Figure 11-9: Global Market for Skin Cancer Drugs Market Share by Leading Supplier 2003
CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS—ANTIVIRALS AND ANTIPARASITICS
- Table 12-1: Common Prescription Topical Antiviral Formulations
- Table 12-2: Common Prescription Topical Antiparasitic Formulations
- Table 12-3: The Global Market for Prescription Miscellaneous Skin Disorder Drugs by Type 1998-2008
- Figure 12-1: The Global Market for Miscellaneous Skin Disorder Drugs Revenues by Type 1998-2008
- Table 12-4: The Global Market for Prescription Miscellaneous Skin Disorder Drugs Market Share by Type 1998-2008
- Table 12-5: The Global Market for Prescription Miscellaneous Drugs by Geographical Region 1998-2008
- Figure 12-2: The Global Market for Prescription Miscellaneous Drugs Revenues by Geographical Region 1998-2008
- Table 12-6: The Global for Prescription Miscellaneous Drugs Market Share by Geographical Region 1998-2008
- Figure 12-3: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2003
- Figure 12-6: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2008
- Table 12-7: The U.S. Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
- Figure 12-5: The U.S. Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
- Table 12-8: The European Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
- Figure 12-6: The European Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
- Table 12-9: The Japanese Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
- Figure 12-7: The Japanese Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
- Table 12-10: The Rest of World Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
- Figure 12-8: The Rest of World Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
CHAPTER THIRTEEN: WORLD MARKET SUMMARY
- Table 13-1: The Global Market for Prescription Dermatological Drugs, Revenues by Segment, 1998-2008
- Figure 13-1: The Global Market for Prescription Dermatological Drugs, Revenues by Dermatological Segment, 1998-2008
- Table 13-2: The Global for Prescription Dermatological Drugs Market Share by Dermatological Segment 1998-2008
- Figure 13-2: The Global Market for Dermatological Drugs Market Share by Type 2003
- Figure 13-3: The Global Market for Prescription Dermatological Drugs Market Share by Type 2008
- Table 13-3: Global Market for Prescription Dermatological Drugs Revenues and Segments of Participation by Leading Market Participants 2003
